About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Eurasian Hematology-Oncology Group
http://www.ehog.net/
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Videos
8th Eurasian Hematology Oncology Summit
XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Palliative & Supportive Care
COVID-19
Basic Science
Leukemia
Lymphoma
Myeloma
MDS and MPN
Benign Hematology
Lung
Business
7th Eurasian Hematology Oncology Summit
COVID-19
Leukemia
Lymphoma
Myeloma
MDS and MPN
Xth Eurasian Hematology-Oncology Congress
Breast
Lung
Hematologic Oncology
Gastrointestinal
Genitourinary
General Oncology
Sarcoma
Skin
Head & Neck
Events
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
P
Hemostasis Changes in Paroxysmal Nocturnal Hemoglobinuria: Is PNH a Prothrombotic State?
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Pierre A. Toulon
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Pierre A. Toulon
19 views
December 30, 2019
0 Comments
Login to view comments.
Click here to Login
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Hematologic Oncology
10:05
Xth Eurasian Hematology-Oncology Congress
Best Abstract Presentation (Francesco Lo Coco Prize) - Adult Hematol…
Feat.
M. Ozbalak
07:09
Xth Eurasian Hematology-Oncology Congress
Best Abstract Presentation (Ekrem Muftuoglu Prize) - Oncology Evalua…
Feat.
S. Çelik
10:30
Xth Eurasian Hematology-Oncology Congress
Best Abstract Presentation (Atilla Yalcin Prize) - Transplant Is The…
Feat.
P. Kaloyannidis
21:36
Xth Eurasian Hematology-Oncology Congress
How I Treat Multiple Myeloma
Feat.
A. Maiolino
22:57
Xth Eurasian Hematology-Oncology Congress
Importance of MRD in Multiple Myeloma: Can MRD Guide Therapy in Newl…
Feat.
E. Terpos
18:10
Xth Eurasian Hematology-Oncology Congress
Impact of Continuous First-Line Therapy in the Treatment of the Firs…
Feat.
A. Ibrahim
23:38
Xth Eurasian Hematology-Oncology Congress
Therapeutic Modulation of The Pleural Effusion Environment: the Next…
Feat.
V. Donnenberg
18:57
Xth Eurasian Hematology-Oncology Congress
The Secretome of Malignant Effusions: The IL-6/sIL-6Ra Axis Appears …
Feat.
A. Donnenberg
24:57
Xth Eurasian Hematology-Oncology Congress
Are Maintenance Post-transplant Therapies Needed: Hypomethylating Ag…
Feat.
K. Halahleh
20:18
Xth Eurasian Hematology-Oncology Congress
Will CAR T-cell Therapy Replace HSCT? The Use of CAR-T Could Further…
Feat.
F. Saglio
25:14
Xth Eurasian Hematology-Oncology Congress
Oral Chronic GVHD Is Common Disease and May Persist for Years, Manag…
Feat.
N. Treister
10:40
Xth Eurasian Hematology-Oncology Congress
Analysis of PFS in CLL: Pts Who Received First-Line Bendamustine-Rit…
Feat.
I. Miroliubova
11:45
Xth Eurasian Hematology-Oncology Congress
Prognostic Implication of NOTCH 1 Expression Among Adult Patients wi…
Feat.
G. Elyamany
16:28
Xth Eurasian Hematology-Oncology Congress
2019 SOHO Update on AML: FLT3 and IDH1/2 Inhibitors, Venetoclax, Ant…
Feat.
G. Garcia-Manero
21:46
Xth Eurasian Hematology-Oncology Congress
Personalizing Prognosis and Treatment of MPN: Historical Milestones …
Feat.
T. Mughal
23:03
Xth Eurasian Hematology-Oncology Congress
The Best Example of Precision Oncology in CML: Response to TKI Thera…
Feat.
G. Saglio
22:56
Xth Eurasian Hematology-Oncology Congress
Precision Oncology in MDS: We Still Don't Know Precise Mechanis…
Feat.
M. Çetiner
15:40
Xth Eurasian Hematology-Oncology Congress
2019 SOHO Update on ALL: Ponatinib -Blinatumomab in Ph+, Ino / Blina…
Feat.
E. Jabbour
14:17
Xth Eurasian Hematology-Oncology Congress
2019 SOHO Updates on CML: Frontline Therapy is Good, Getting Better …
Feat.
E. Jabbour
19:17
Xth Eurasian Hematology-Oncology Congress
2019 SOHO Updates on MDS: Treatment of CHIP, New Approach for Anemia…
Feat.
G. Garcia-Manero
16:04
Xth Eurasian Hematology-Oncology Congress
St-Petersburg Hematological Centre Experience on the Use of BMT in R…
Feat.
N. Mikhailova
14:22
Xth Eurasian Hematology-Oncology Congress
Kirov Hematological Institute Analysis of Donors Register: Unrelated…
Feat.
M. Loginova
13:40
Xth Eurasian Hematology-Oncology Congress
Bone Marrow Allogenic Transplantation in Relapsed/ Refractory Hem Ma…
Feat.
I. Moiseev
20:34
Xth Eurasian Hematology-Oncology Congress
Should ALL Treatment be Driven by MRD Detection? IOs Result in Highe…
Feat.
D. Hoelzer
20:45
Xth Eurasian Hematology-Oncology Congress
2019 Therapy of Ph+ ALL: Which TKIs, Dosing and Schedule, Intensity,…
Feat.
O. Ottmann
12:21
Xth Eurasian Hematology-Oncology Congress
Ph-like ALL Should Be Treated as the Other B ALL After Demonstration…
Feat.
O. Ottmann
24:55
Xth Eurasian Hematology-Oncology Congress
Overview of Current Therapeutic Options in AML of Young Adults: New …
Feat.
M. Yilmaz
22:53
Xth Eurasian Hematology-Oncology Congress
Risk Stratification and Treatment of CLL: If New Drugs Available, 17…
Feat.
R. Foa
22:05
Xth Eurasian Hematology-Oncology Congress
Therapeutic Approach for CLL Biomarkers: Low-Risk Should Be Treated …
Feat.
P. Panayiotidis
22:53
Xth Eurasian Hematology-Oncology Congress
New Drugs Have an Established Role in CLL: BCR and BCL2 Inhibitors (…
Feat.
R. Foa
13:19
Xth Eurasian Hematology-Oncology Congress
Moscow National Hematological Centre Experience on the Role and Plac…
Feat.
L. Mendeleeva,
M. Solovev
07:20
Xth Eurasian Hematology-Oncology Congress
Ph-like ALL Therapy Should Be Different From the Other B-ALL: Target…
Feat.
D. Hoelzer
23:09
Xth Eurasian Hematology-Oncology Congress
Hemostasis Changes in Paroxysmal Nocturnal Hemoglobinuria: Is PNH a …
Feat.
P. Toulon
26:52
Xth Eurasian Hematology-Oncology Congress
Managing Paroxysmal Nocturnal Hemoglobinuria: Chronic Complement-Med…
Feat.
B. Antmen
21:11
Xth Eurasian Hematology-Oncology Congress
Eosinophilia and Mastocytosis: TKIs are SOC for PDGFRa/b Mutations, …
Feat.
H. Hamed
19:25
Xth Eurasian Hematology-Oncology Congress
Approaching Consensus in Immune Thrombocytopenic Purpura: Adult ITP …
Feat.
D. Provan
